Promotion or education: a content analysis of industry-authored oral health educational materials targeted at acute care nurses

Potential Allergenicity of Plants Used in Allergological Communication: An Untapped Tool for Prevention

Plants are often used to illustrate allergy-related medical products, services, patient information materials and news. The illustration of allergenic plants is an important tool in patient education, contributing to the prevention of pollinosis, as patients can recognize plants and avoid pollen exposure. In this study, it is aimed to evaluate the pictorial content of allergy-related websites depicting plants. A total of 562 different photographs depicting plants were collected using image search, identified and categorized according to their potential allergenicity. Of the total 124 plant taxa, 25% of plants were identified to the genus level and a further 68% were identified to the species level. Plants with low allergenicity were found in 85.4% of the pictures, while plants of high allergenicity were shown in only 4.5% of the pictorial information. Brassica napus was the most frequent species identified (8.9% of the overall identified plants), while blooming Prunoidae, Chrysanthemum spp. and Taraxacum officinale were also common. Considering both allergological and design aspects, some plant species have been proposed for more professional and responsible advertising. The internet has the potential to provide visual support for patient education in allergenic plants, but emphasis must be put on the transmission of the correct visual message.

How the Suboxone Education Programme presented as a solution to risks in the Canadian opioid crisis: a critical discourse analysis

OBJECTIVES

Pharmaceutical industry involvement in medical education, research and clinical practice can lead to conflicts of interest. Within this context, this study examined how the 'Suboxone Education Programme', developed and delivered by a pharmaceutical company as part of a federally regulated risk management program, was presented as a solution to various kinds of risks relating to opioid use in public documents from medical institutions across Canada.

SETTING

These documents were issued during the Canadian opioid crisis, a time when the involvement of industry in health policy was being widely questioned given industry's role in driving the overprescribing of opioid analgesics and contributing to population-level harms.

DESIGN

A critical discourse analysis of 69 documents collected between July 2020 and May 2021 referencing the Suboxone Education Program spanning 13 years (2007-2021) from medical, nursing and pharmacy institutions sourced from every Canadian province and territory. Discursive themes were identified through iterative and duplicate analyses using a semistructured data extraction instrument.

RESULTS

Documents characterised the Programme as addressing iatrogenic risks from overprescribing opioid analgesics, environmental risks from a toxic street drug supply and pharmacological risks relating to the dominant therapeutic alternative of methadone. The programme was identified as being able to address these risks by providing mechanisms to surveil healthcare professionals and to facilitate the prescribing of Suboxone. Medical institutions legitimised the Suboxone Education Programme by lending their regulatory, epidemiological and professional authority.

CONCLUSIONS

Addressing risk is considered as a central, moral responsibility of contemporary healthcare services. In this case, moral imperatives to address opioid crisis-related risks overrode other ethical concerns regarding conflicts of interest between industry and public welfare. Failing to address these conflicts potentially imperils efforts of mitigating population health harms by propagating an important driving force of the opioid crisis.